Zenith Healthcare Limited has formally declared to the Bombay Stock Exchange that it does not qualify as a 'Large Corporate' under SEBI regulations for the financial year ended March 31, 2026. The pharmaceutical company submitted its compliance declaration on April 11, 2026, confirming non-applicability of specific disclosure requirements.

SEBI Compliance Declaration

The company's declaration pertains to SEBI Circular SEBI/HO/DDHS/CIR/P/144 dated November 26, 2018, which governs the raising of funds through debt securities by large corporate entities. Zenith Healthcare Limited confirmed that these provisions do not apply to its operations as it does not meet the criteria for classification as a 'Large Corporate' under the specified framework.

Financial Position Details

The company provided key financial metrics to support its non-applicability status:

Corporate Authorization

The declaration was formally authorized by three key executives of Zenith Healthcare Limited:

• Mahendra C. Raycha - Chairman & Managing Director (DIN: 00577647)
• Mihir S. Shah - Company Secretary & Compliance Officer (Membership No: A41922)
• Prashant Gupta - Chief Financial Officer

All three officials digitally signed the compliance documents on April 11, 2026, ensuring proper corporate governance and regulatory adherence.

Regulatory Framework Context

The SEBI circular in question establishes specific criteria for identifying large corporate entities and mandates certain disclosure requirements for fund raising through debt securities. Companies that do not meet the threshold criteria must submit formal declarations confirming their non-applicability status to maintain compliance with exchange listing requirements.

Zenith Healthcare Limited's proactive submission of this declaration demonstrates its commitment to maintaining transparent regulatory compliance and ensuring accurate classification under current SEBI frameworks for the financial year 2026.

Zenith Health Care Limited has submitted its quarterly regulatory declaration under Regulation 74(5) of the Depositories and Participants Regulations 2018 for the quarter ended March 31, 2026. The pharmaceutical company filed the mandatory compliance document with BSE on April 11, 2026.

Regulatory Filing Details

The company submitted the declaration through its Company Secretary and Compliance Officer, Mihir S Shah (Membership No: A41922). The filing was made under reference number ZHL/LIST/BSE/LODR/REG-74(5)/03-2026 and addressed to the Listing Compliance Department of BSE Limited.

RTA Certificate Confirmation

The submission included a certificate from Bigshare Services Private Limited, the company's Registrar and Share Transfer Agent (SEBI Registration Number INR000001385). The certificate, dated April 6, 2026, and issued under reference number BSS/74(5), confirms the company's compliance with dematerialization requirements.

Bigshare Services confirmed that securities received from depository participants for dematerialization up to March 31, 2026, were properly processed and confirmed to the depositories. The RTA also verified that all security certificates received for dematerialization were mutilated and cancelled after due verification by depository participants.

Compliance Framework

The declaration ensures compliance with multiple regulatory frameworks, including NSDL circular NSDL/CIR/II/5/2019 dated January 25, 2019, and CDSL circular DSL/OPS/RTA/POLICY/2019/14 dated January 25, 2019. The filing also references SEBI letter MRD/DOP2/DSA2/OW/2019/2498/1 dated January 24, 2019.

Operational Infrastructure

Zenith Healthcare Limited operates from its registered office at 504, Iscon Elegance, Near Ananddham Jain Derasar, Prahladnagar Cross Road, S.G. Road, Ahmedabad-380015. The company maintains manufacturing units at Changodar Industrial Estate and Bhat, Ahmedabad, along with a dedicated godown facility. The WHO-cGMP and ISO 9001:2008 certified company continues to maintain proper connectivity with both NSDL and CDSL depositories through its registered transfer agent.